Contrast-induced nephropathy

Area of Science:

• Nephrology
• Radiology
• Vascular Surgery

Background:

• Contrast-induced nephropathy (CIN) is a significant cause of hospital-acquired kidney injury.
• Increasing use of contrast media in endovascular therapies necessitates CIN risk reduction strategies.
• Existing CIN prevention research predominantly focuses on coronary interventions, with limited data for vascular surgery patients.

Purpose of the Study:

• To review current strategies for preventing CIN in patients undergoing vascular interventions.
• To highlight the importance of adequate hydration and evaluate pharmacological and procedural interventions.

Main Methods:

• Literature review of trials, meta-analyses, and guidelines on CIN prevention (1966-2006).
• Focus on studies relevant to vascular intervention populations.
• Analysis of evidence for hydration, pharmacological agents, forced diuresis, hemodialysis, and hemofiltration.

Main Results:

• Adequate hydration is consistently recommended for all patients receiving contrast media.
• No pharmacological agents have demonstrated conclusive efficacy in reducing CIN risk.
• Forced diuresis is considered potentially harmful; evidence for routine hemodialysis or hemofiltration is insufficient.

Conclusions:

• Hydration remains the cornerstone of CIN prevention in vascular interventions.
• Further well-designed studies are needed to evaluate prophylactic techniques specifically in vascular patient populations.
• Current evidence does not support routine use of pharmacological agents, forced diuresis, hemodialysis, or hemofiltration for CIN prevention.